You have 9 free searches left this month | for more free features.

oncology or haematology patient who is or has received chemotherapy or who is immunocompromised as a result of their disease or treatment

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Covid19 Trial in United Kingdom (Niclosamide, Placebo, Ciclesonide)

Recruiting
  • Covid19
  • Cambridge, Cambridgeshire, United Kingdom
  • +34 more
Feb 20, 2022

Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • COVID-19 vaccine
  • Montréal, Quebec, Canada
  • +1 more
Jan 13, 2023

Cancer, Aging, Communication Trial in Houston (Geriatric Assessment)

Recruiting
  • Cancer
  • +2 more
  • Geriatric Assessment
  • Houston, Texas
    MD Anderson Cancer Center
Aug 16, 2022

Immunocompromised Haematology Patients

Active, not recruiting
  • Covid19
  • +2 more
  • Blood test
  • Stoke-on-Trent, United Kingdom
    University Hospitals of North Midlands NHS Trust
Feb 17, 2022

Cancer, Chemotherapeutic Agent Toxicity Trial in Santiago (Contigo Application)

Not yet recruiting
  • Cancer
  • Chemotherapeutic Agent Toxicity
  • Contigo Application
  • Santiago, Chile
    Complejo Asistencial Dr. Sotero del Río
Oct 10, 2023

Onco-haematology Vigilance Card

Recruiting
  • Medical Oncology
  • +2 more
    • Limoges, France
      CHU de Limoges
    Nov 2, 2021

    Quality of Life, Oral Mucositis, Dental Plaque Trial in Barcelona (The probiotic to be used in the intervention corresponds to

    Enrolling by invitation
    • Quality of Life
    • +5 more
    • The probiotic to be used in the intervention corresponds to PRODEFEN Plus manufactured by ITALFARMACO S.A. laboratory
    • Placebo
    • Barcelona, Spain
      University of Barcelona
    Nov 9, 2023

    Breast Cancer, Nursing Trial in Ankara (Mobile Application with Interactive Nurse Support)

    Recruiting
    • Breast Cancer
    • Nursing
    • Mobile Application with Interactive Nurse Support
    • Ankara, Çankaya, Turkey
      Ankara Bilkent City Hospital
    Feb 12, 2023

    Respiratory Tract Viral Infection Trial in Poitiers (nasal swabs)

    Recruiting
    • Respiratory Tract Viral Infection
    • nasal swabs
    • Poitiers, France
      University Hospital of Poitiers
    Feb 1, 2022

    Cancer Trial in Istanbul (Community Supported Videos)

    Recruiting
    • Cancer
    • Community Supported Videos
    • Istanbul, Zeytinburnu, Turkey
      Koc University
    Aug 30, 2023

    Treatment Side Effects Trial (the Mandarin Version of the electronic patient self-Reporting of Adverse-events (eRAPID-MV), the

    Not yet recruiting
    • Treatment Side Effects
    • the Mandarin Version of the electronic patient self-Reporting of Adverse-events (eRAPID-MV)
    • the telephone triage decision support system (TTDSS)
    • (no location specified)
    Aug 9, 2022

    COVID-19, SARS-CoV-2 Trial in Worldwide (AZD1222)

    Active, not recruiting
    • COVID-19, SARS-CoV-2
    • AZD1222
    • Ajmer, India
    • +12 more
    Nov 10, 2022

    Chemo Effect Trial in Montréal (Comfort Talk)

    Completed
    • Chemotherapy Effect
    • Comfort Talk
    • Montréal, Quebec, Canada
      Hôpital du Sacré-Coeur de Montréal
    Mar 14, 2022

    Second Opinions in Oncology

    Recruiting
    • Breast Cancer
    • +2 more
      • Aurora, Colorado
        University of Colorado Hospital
      Aug 22, 2022

      Patient Engagement, Patient Activation, Patient Reported Outcome Measures Trial in Toronto (At-home Breast Oncology care

      Recruiting
      • Patient Engagement
      • +2 more
      • At-home Breast Oncology care Delivered with E-health solutions - ABODE
      • Toronto, Ontario, Canada
        Tulin Cil
      Aug 9, 2023

      Solid Carcinoma Trial (thrombogram)

      Not yet recruiting
      • Solid Carcinoma
      • thrombogram
      • (no location specified)
      Sep 20, 2023

      Diarrhea, Cancer Trial in Bratislava (PROBIO-FIX INUM®, Placebo)

      Completed
      • Diarrhea
      • Cancer
      • Probio-Tec® BG-VCap-6.5
      • Placebo
      • Bratislava, Slovakia
        National Cancer Institute
      Dec 12, 2022

      Pediatric Cancer Trial in Antalya (Occupation-based nursing program, Control Group)

      Recruiting
      • Pediatric Cancer
      • Occupation-based nursing program
      • Control Group
      • Antalya, Konyaaltı, Turkey
        Şule Şenol
      Aug 2, 2022

      Sickle Cell Disease Trial in Heidelberg

      Recruiting
      • Sickle Cell Disease
        • Heidelberg, BW, Germany
          Center for Child and Adolescent Medicine, University Medical Cen
        Nov 5, 2022

        Participants Undergoing Anthracycline Chemo Trial in Cincinnati (autoRIC®)

        Recruiting
        • Participants Undergoing Anthracycline Chemotherapy
        • autoRIC®
        • Cincinnati, Ohio
          Cincinnati Children's Hospital
        Jun 24, 2022

        Lymphoma Trial in Haifa (procedure, dietary supplement, behavioral)

        Recruiting
        • Lymphoma
        • Acupuncture
        • +5 more
        • Haifa, Israel
          Bnai Zion Medical Center
        Jul 30, 2023

        Natural History of Disease in Patients Treated With Radiotherapy

        Recruiting
        • Cancer
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 25, 2023

          Precise Prediction of Therapy Efficiency Trial (biopsy of tumor before treatment)

          Not yet recruiting
          • Precise Prediction of Therapy Efficiency
          • biopsy of tumor before treatment
          • (no location specified)
          Jan 31, 2023

          Relapsed Pediatric ALL, Relapsed Pediatric AML, Refractory Acute Myeloid Leukemia Trial in Kansas City (Daunorubicin)

          Recruiting
          • Relapsed Pediatric ALL
          • +3 more
          • Kansas City, Missouri
            Children's Mercy Hospital
          Jul 1, 2022

          Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

          Not yet recruiting
          • Metastatic Breast Cancer
          • +2 more
          • Patritumab deruxtecan
          • (no location specified)
          May 9, 2023